Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which lung drain method wins? study pits manual suction against gravity

NCT ID NCT07184736

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested two methods for draining excess fluid from around the lungs (pleural effusion) in 60 adults with severe shortness of breath. One group had fluid removed by a doctor using a manual syringe (active aspiration), while the other let fluid drain out by gravity. Researchers measured how long each method took, how much fluid was removed, and how much pain or cough patients experienced. The goal is to find which technique is more efficient and comfortable for patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one method proves faster and more comfortable, it could become the preferred technique for draining fluid from the lungs.
What could go wrong
This is a small, completed study with only 60 participants, so results may not apply to all patients. Neither method is new, so no breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2020

Finished

Mar 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients of either gender. * Aged above 18 years. * With symptomatic large pleural effusion (either exudative or transudative). * Requiring therapeutic pleurocentesis. * Modified Medical Research Council (mMRC) dyspnea scale grade 3-4. Exclusion Criteria: * Uncorrected bleeding diathesis. * Chest wall cellulitis at the intended site of puncture. * Uncooperative patients. * Loculated pleural effusion. * Traumatic hemothorax. * Empyema thoracis. * Hydropneumothorax. * Patients who refused to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pleural effusion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pleural Effusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sheikh Zayed Hospital

    Lahore, Punjab Province, 54470, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.